Kazar J, Gillmore J, GORDON F
Infect Immun. 1971; 3(6):825-32.
PMID: 16558062
PMC: 416245.
DOI: 10.1128/iai.3.6.825-832.1971.
Kazar J, Krautwurst P, GORDON F
Infect Immun. 1971; 3(6):819-24.
PMID: 16558061
PMC: 416244.
DOI: 10.1128/iai.3.6.819-824.1971.
Hugh R, Huang K, Elliott T
Infect Immun. 1971; 3(3):488-93.
PMID: 16558000
PMC: 416178.
DOI: 10.1128/iai.3.3.488-493.1971.
BERRY L, Smythe D, Colwell L, Schoengold R, Actor P
Infect Immun. 1971; 3(3):444-8.
PMID: 16557994
PMC: 416172.
DOI: 10.1128/iai.3.3.444-448.1971.
Gifford G, Tibor A, Peavy D
Infect Immun. 1971; 3(1):164-6.
PMID: 16557935
PMC: 416123.
DOI: 10.1128/iai.3.1.164-166.1971.
Evidence for the presence of lipopolysaccharide in a ribonuclease-sensitive ribosomal vaccine of Pseudomonas aeruginosa.
Gonggrijp R, Volleberg M, Lemmens P, van Boven C
Infect Immun. 1981; 31(3):896-905.
PMID: 6785242
PMC: 351403.
DOI: 10.1128/iai.31.3.896-905.1981.
Serotype-nonspecific protection induced by ribonucleic acid isolated from the ribosomal vaccine of Pseudomonas aeruginosa.
Gonggrijp R, Mullers W, van Boven C
Infect Immun. 1981; 33(1):178-85.
PMID: 6167518
PMC: 350675.
DOI: 10.1128/iai.33.1.178-185.1981.
Ultrastructural changes in chick cerebellum induced by polyinosinic polycytidylic acid.
Yu M, Young P, Yu W
Am J Pathol. 1971; 64(2):305-20.
PMID: 5142269
PMC: 2047580.
Early protection by vaccines in burns.
Jones R
Br J Exp Pathol. 1971; 52(1):100-9.
PMID: 4993954
PMC: 2072283.
Effect of interferon inducers and interferon on bacterial infections.
Giron D, Schmidt J, Ball R, Pindak F
Antimicrob Agents Chemother. 1972; 1(1):80-1.
PMID: 4670434
PMC: 444170.
DOI: 10.1128/AAC.1.1.80.
Vaccines and cell-mediated immunity.
Collins F
Bacteriol Rev. 1974; 38(4):371-402.
PMID: 4613342
PMC: 413869.
DOI: 10.1128/br.38.4.371-402.1974.
The stimulation by endotoxin of the nonspecific resistance of mice to bacterial infections.
HILL A, Hibbitt K, Shears A
Br J Exp Pathol. 1974; 55(2):194-202.
PMID: 4599349
PMC: 2072531.
Nonspecific protective action against Vibrio cholerae of SK&F 42319, a ribonucleic acid obtained from bacteriophage-infected Escherichia coli.
Actor P, Pitkin D, Goore M, BERRY L
Infect Immun. 1972; 6(5):886-8.
PMID: 4564788
PMC: 422626.
DOI: 10.1128/iai.6.5.886-888.1972.
Suppression of the intracellular growth of Shigella flexneri in cell cultures by interferon preparations and polyinosinic-polycytidylic acid.
Gober L, Friedman-Kien A, Havell E, Vilcek J
Infect Immun. 1972; 5(3):370-6.
PMID: 4564562
PMC: 422377.
DOI: 10.1128/iai.5.3.370-376.1972.
Effect of an interferon stimulator, polyinosinic: polycytidylic acid, on experimental fungus infections.
Worthington M, Hasenclever H
Infect Immun. 1972; 5(2):199-202.
PMID: 4564399
PMC: 422348.
DOI: 10.1128/iai.5.2.199-202.1972.
Short term effects of nonspecific resistance induced by endotoxin on the distribution and viability of bacteria injected into mice.
HILL A, Hibbitt K, Shears A
Br J Exp Pathol. 1974; 55(5):448-52.
PMID: 4451634
PMC: 2072683.
Increased toxicity of double-stranded ribonucleic acid in virus-infected animals.
De Clercq E, Stewart 2nd W, DE SOMER P
Infect Immun. 1973; 7(2):167-72.
PMID: 4348963
PMC: 422655.
DOI: 10.1128/iai.7.2.167-172.1973.
Enhancement of phagocytosis by interferon-containing preparations.
Huang K, Donahoe R, GORDON F, DRESSLER H
Infect Immun. 1971; 4(5):581-8.
PMID: 4343410
PMC: 416356.
DOI: 10.1128/iai.4.5.581-588.1971.
Dose responsiveness and variation among inbred strains of mice in production of interferon after treatment with poly (I)-poly (C) (poly-D-lysine) complexes.
Rice J, Turner W, Chirigos M, Spahn G
Appl Microbiol. 1971; 22(3):380-6.
PMID: 4330315
PMC: 376318.
DOI: 10.1128/am.22.3.380-386.1971.
The role of interferon in the protective effect of a synthetic double-stranded polyribonucleotide against intranasal vesicular stomatitis virus challenge in mice.
De Clercq E, Nuwer M, Merigan T
J Clin Invest. 1970; 49(8):1565-77.
PMID: 4317283
PMC: 322636.
DOI: 10.1172/JCI106374.
